JPIAMR has today published research output and impact from three of the seven projects funded in the first JPIAMR Joint Call 2014, Innovative approaches to address antibacterial resistance. This call was promoted by 14 funding agencies in 12 countries, and had a total budget of 13,8 M€. The projects have resulted in a pending patent for a TB compound, a new approach to interrupting bacteria communications, and innovations to make existing antibiotics remain effective.
Jan-Ingvar Jönsson, Acting Chair JPIAMR Management Board, says:
– Results generated from this call shows how JPIAMR funding can make a difference, and lead to ground-breaking research and innovations.
Read more on each project in the folder and research spotlights below:
- Achievements of 1st Joint Call: Innovative approaches to address antibacterial resistance (pdf 0,2 MB, opens in a new window)
- NACPLI: Non-conventional approaches for peptidoglycan cross-linking inhibition (pdf 0,2 MB, opens in a new window)
- noTBSec: New intervention strategy for tuberculosis by blocking multiple essential targets (pdf 0,2 MB, opens in a new window)
- SENBIOTAR: Sensitising Pseudomonas aeruginosa biofilms to antibiotic and reducing virulence through novel target inhibition (pdf 0,2 MB, opens in a new window)
